Nanjing Vazyme Biotech Co., Ltd (SHA:688105)
19.89
-0.79 (-3.82%)
Nov 17, 2026, 3:00 PM CST
| Market Cap | 10.28B +8.5% |
| Revenue (ttm) | 1.56B +15.8% |
| Net Income | 993.15K |
| EPS | 0.00 |
| Shares Out | 516.99M |
| PE Ratio | 13,111.40 |
| Forward PE | 143.00 |
| Dividend | 0.38 (1.93%) |
| Ex-Dividend Date | Jun 3, 2026 |
| Volume | 6,531,279 |
| Open | 20.41 |
| Previous Close | 20.68 |
| Day's Range | 19.73 - 20.94 |
| 52-Week Range | 12.89 - 29.16 |
| Beta | 0.70 |
| Analysts | Strong Buy |
| Price Target | 24.24 (+21.87%) |
| Earnings Date | Oct 29, 2026 |